Telix Pharmaceuticals Secures License to Cancer Treatments in Germany

MT Newswires11/19 08:54

Telix to Add FAP-Targeting Candidates to Theranostic Pipeline

PR Newswire11/19 06:24

UBS Initiates Coverage On Telix Pharmaceuticals With Buy Rating, Announces Price Target of $21

Benzinga11/15 20:26

Telix Pharmaceuticals Analyst Ratings

Benzinga11/15 20:22

Telix ADSs Commence Trading on Nasdaq

GlobeNewswire11/14 05:28

Subtle Medical Unveils Subtle-ELITE and New Strategic Partnerships at RSNA 2024

PR Newswire11/13 20:50